Cargando…
Sorafenib improves the postoperative effect of early stage renal cell carcinoma
Sorafenib was examined to determine whether it improves postoperative effects during early stage renal cell carcinoma (RCC). A total of 133 patients with early renal clear cell carcinoma (T1-2N0M0) with surgical indications were continuously selected. The patients were divided into 3 groups accordin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228338/ https://www.ncbi.nlm.nih.gov/pubmed/28105151 http://dx.doi.org/10.3892/ol.2016.5243 |